DOJ Looking Into Possible Price Collusion in Generic Drug Sector -Bloomberg
November 03 2016 - 4:08PM
Dow Jones News
A Justice Department probe of possible price collusion by
generic drug companies could lead to criminal charges by the end of
the year, Bloomberg News reported Thursday.
The investigation spans more than a dozen companies, Bloomberg
reported, citing people familiar with the matter.
Shares of several generic drug makers declined following the
report. Among them were Lannett Co. (LCI), which fell 26% to
$17.30, Endo International PLC (ENDP), which was down 18% to $14.85
and Teva Pharmaceutical Industries Ltd. (TEVA), down 12% to
$38.02.
Full story at
http://www.bloomberg.com/news/articles/2016-11-03/u-s-charges-in-generic-drug-probe-said-to-be-filed-by-year-end
Write to nymonitoring@dowjones.com
(END) Dow Jones Newswires
November 03, 2016 15:53 ET (19:53 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Impax labs (NASDAQ:IPXLE)
Historical Stock Chart
From Dec 2024 to Jan 2025
Impax labs (NASDAQ:IPXLE)
Historical Stock Chart
From Jan 2024 to Jan 2025
